Baird Medical Investment Holdings Ltd Ordinary Share (BDMD) is a publicly traded Healthcare sector company. As of July 26, 2026, BDMD trades at $1.02 with a market cap of $32.62M and a P/E ratio of 0.00. BDMD moved +0.00% today. Year to date, BDMD is -25.00%; over the trailing twelve months it is -52.56%. Its 52-week range spans $0.76 to $12.50. Rallies surfaces BDMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Baird Medical Records First Ablations in Vietnam on June 18 and Argentina on June 15: Baird Medical completed its first microwave ablation procedure in Vietnam on June 18 to treat a benign thyroid nodule and its first liver ablation in Argentina on June 15. These landmark cases expand the company’s FDA 510(k)-cleared minimally invasive technology into two new markets.
| Metric | Value |
|---|---|
| Price | $1.02 |
| Market Cap | $32.62M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.50 |
| 52-Week Low | $0.76 |
| Volume | 37.20K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
BDMD analyst coverage data. Average price target: $0.00.